Novo Nordisk stock falls 0.5 percent ahead of the open
Published on 09/24/2026 at 08:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Novo Nordisk stock closed at DKK 257.50 on Nasdaq Copenhagen on September 23, 2026, down 0.5 percent. The shares remained DKK 33.20 above their 52-week low and DKK 152.50 below their 52-week high.
September 23, 2026 in numbers
Novo Nordisk A/S (ISIN DK0060534915, Nasdaq Copenhagen: NOVO B) traded 1,291,665 shares during the session, according to the dated market data. The 52-week range was DKK 224.30 to DKK 410.00, placing the close 14.8 percent above the low and 37.2 percent below the high.
As Ad-hoc-news reported on September 23, 2026, the company targeted more than DKK 150 billion in risk-adjusted pipeline sales by 2035 and more than five potential blockbuster launches by 2030. That strategy followed the Capital Markets Day and framed the session backdrop.
Strategy focus today
The strategy remains relevant for today as investors assess the company target of matching broader pharmaceutical-industry growth through 2030. CNBC reported on September 24, 2026, that the Capital Markets Day plan included more than five potential blockbuster drugs by 2030.
